Search

everythinglearnresearchcommunity

for

Search:↓

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

The treatment is safe and shows promise for metastatic breast cancer.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Targeted cancer therapies often cause serious skin problems that need careful management.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Intralesional triamcinolone acetonide is preferred for treating patchy alopecia areata due to fewer side effects.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Cetuximab can cause unusual hair growth and hair loss.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Clofazimine effectively treated ashy dermatosis in a patient.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.